
Rising costs, heavy investment that outpaced growth and patent litigation led California-based biotechnology company Synthego Corp. to file for Chapter 11 with up to $500 million in debt and a plan to sell its assets to a prepetition lender.

Market Brief
Daily market recaps with key events, stock movements, and global influences
A newer version of this article is available. Read the latest version
21 posts • GPT (4.1 mini)
Published
More breaking stories on DeepNewz — updated live.
Rising costs, heavy investment that outpaced growth and patent litigation led California-based biotechnology company Synthego Corp. to file for Chapter 11 with up to $500 million in debt and a plan to sell its assets to a prepetition lender.
RNS mutters abt a 'compromise Restructuring Plan payment' for wiped out shrhldrs... ...but rest assured, it'll be a token amt, maybe $0.001/share ('cos TINA!). But in true #ARB fashion, despite today's (69)% dump, punters are STILL valuing its ZEROED equity at $9 MILLION..!
$ARB.L $ARBK Final farewell to insolvent #ArgoBlockchain which has finally managed a restructuring (& will de-list), WIPING OUT existing shrhldrs... ...#ARB down (68)%, as I still await LOTS of apologies from emotional punters I warned ALL THE WAY DOWN!